Genetic variants of the EGFR ligand-binding domain and their association with structural alterations in Arab cancer patients.

Abstract

OBJECTIVE:

This study aimed to identify novel genetic variants in the CR2 extracellular domain of the epidermal growth factor receptor (EGFR) in healthy individuals and patients with six different types of adenocarcinoma, in Arabian peninsula populations. It also aimed to investigate the effects of these variants on the EGFR structure and their eventual relevance to tumorigenesis.

RESULTS:

We detected seven new EGFR genetic variants in 168 cancer patients and 114 controls. A SNP rs374670788 was more frequent in bladder cancer but not significantly associated to. However, a missense mutation (V550M) was significantly associated to colon, ovary, lung, bladder and thyroid cancer samples (p < 0.05). Three mutations (H590R, E602K and T605T) were found in the heterozygous form only in colon cancer patients. Genomic analysis of the synonymous mutation (G632G) showed that the T/A genotype could be associated to thyroid cancer in Arab patients (p < 0.05). An additional novel SNP rs571064657 was observed in control individuals. Computational analysis of the genetic variants revealed a reduction in the stabilization of the EGFR tethered form for both V550M and the common R521K variant with low energetic state (- ∆∆G). Molecular interactions analysis suggested that these mutations might affect the receptor's function and promote tumorigenesis.

• Authors: Maryam Marzouq, Ali Nairouz, Noureddine Ben Khalaf, Sonia Bourguiba-Hachemi, Raed Quaddorah, Dana Ashoor, M Dahmani Fathallah
• Journal: BMC research notes (BMC Res Notes) Vol. 14 Issue 1 Pg. 146 (Apr 19 2021) ISSN: 1756-0500 [Electronic] England
• PMID: 33874989 (Publication Type: Journal Article)

Chemical References

• Ligands
• EGFR protein, human
• ErbB Receptors

Topics

• Adenocarcinoma
• Arabs (genetics)
• ErbB Receptors (genetics)
• Female
• Humans
• Ligands
• Lung Neoplasms
• Mutation